Skip to main content
    N

    Neuronetics Inc (STIM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.39
    -0.04 (-2.80%)

    Market Cap: $134.10M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Neuronetics Inc (STIM) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Neuronetics reported revenue of $149.16M for the fiscal year ended Dec 31, 2025, up 99.2% from the year before. That year, net income was -$39.13M with a net margin of -26.2%, operating cash flow was -$20.37M and free cash flow was -$21.18M. The quarter ended Sep 30, 2026 had revenue of $41.96M and net income of -$1.56M.

    Revenue and Margins

    The operating margin was -21.1% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $34.23M, a compound annual rate of 17.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$149.16M+99.2%48.5%-21.1%-26.2%
    Dec 2024$74.89M+5.0%72.3%-46.2%-58.4%
    Dec 2023$71.35M+9.4%72.5%-42.8%-42.3%
    Dec 2022$65.21M+17.9%76.3%-53.8%-57.0%
    Dec 2021$55.31M+12.3%78.9%-49.8%-56.4%
    Dec 2020$49.24M-21.4%76.5%-45.3%-55.7%
    Dec 2019$62.66M+18.7%75.4%-43.0%-46.4%
    Dec 2018$52.78M+30.5%76.4%-37.6%-45.7%
    Dec 2017$40.43M+18.1%76.2%-33.7%-39.7%
    Dec 2016$34.23MN/A80.7%-27.3%-32.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$149.16M$74.89M$71.35M$65.21M$55.31M$49.24M$62.66M$52.78M$40.43M$34.23M
    Cost of revenue$76.85M$20.73M$19.64M$15.48M$11.65M$11.55M$15.39M$12.45M$9.63M$6.62M
    Gross profit$72.31M$54.16M$51.70M$49.72M$43.66M$37.69M$47.27M$40.33M$30.80M$27.61M
    Research and development$6.58M$12.77M$9.52M$9.34M$7.92M$9.20M$13.75M$8.23M$7.94M$8.22M
    Operating income-$31.44M-$34.56M-$30.55M-$35.11M-$27.56M-$22.31M-$26.93M-$19.83M-$13.61M-$9.34M
    Net income-$39.13M-$43.73M-$30.19M-$37.16M-$31.19M-$27.45M-$29.04M-$24.10M-$16.06M-$11.23M
    EBITDA-$26.43M-$29.17M-$22.13M-$30.55M-$25.40M-$19.87M-$23.54M-$18.69M-$11.93M-$8.34M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$41.96M$41.57M$34.45M$41.78M$37.30M$38.11M$31.98M$22.49M$18.53M$16.45M$17.42M$20.31M
    Gross profit$21.89M$21.22M$16.15M$21.70M$17.11M$17.76M$15.74M$14.89M$14.00M$12.18M$13.09M$15.77M
    Operating income$541.00K-$1.50M-$8.99M-$5.04M-$7.32M-$8.06M-$11.01M-$11.47M-$7.73M-$8.51M-$6.86M-$4.43M
    Net income-$1.56M-$3.46M-$10.78M-$7.21M-$9.40M-$9.84M-$12.69M-$12.68M-$13.34M-$9.83M-$7.87M-$5.38M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $66.31M exceeded cash and equivalents by $38.17M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$141.55M$140.90M$115.83M$116.88M$141.22M$78.66M$100.17M$117.02M$38.94M$24.80M
    Current assets$61.55M$58.12M$93.79M$98.77M$115.33M$65.01M$88.45M$114.47M$37.01M$22.92M
    Cash and equivalents$28.13M$18.46M$59.68M$70.34M$94.14M$48.96M$75.71M$104.58M$29.15M$17.04M
    Total liabilities$115.31M$109.10M$81.64M$59.82M$56.05M$53.16M$52.32M$45.98M$44.45M$201.92M
    Short-term debt$500.00K$1.00M$0$13.13M$0$594.00K$11.25MN/A$29.56M$4.49M
    Long-term debt$65.81M$55.15M$59.28M$22.83M$35.34M$34.62M$19.90M$30.39M$29.56M$15.65M
    Shareholder equity$22.38M$27.71M$34.19M$57.06M$85.17M$25.49M$47.85M$71.04M-$192.65M-$177.12M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$131.96M$131.53M$125.44M$141.55M$145.47M$134.65M$141.99M$140.90M$74.12M$96.81M$103.81M$115.83M
    Total liabilities$109.56M$109.89M$108.38M$115.31M$114.11M$103.14M$102.46M$109.10M$64.74M$77.43M$76.16M$81.64M
    Cash and equivalents$22.11M$19.20M$13.21M$34.13M$27.97M$10.97M$20.22M$19.46M$20.87M$42.64M$47.73M$59.68M
    Shareholder equity$18.71M$17.85M$13.27M$22.38M$27.36M$27.15M$35.45M$27.71M$9.38M$19.39M$27.66M$34.19M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$20.37M-$31.00M-$32.04M-$30.74M-$27.98M-$28.39M-$30.48M-$20.59M-$11.14M-$8.54M
    Capital expenditures$801.00K$1.47M$2.37M$3.27M$2.35M$730.00K$813.00K$1.01M$594.00K$324.00K
    Free cash flow-$21.18M-$32.46M-$34.41M-$34.01M-$30.34M-$29.12M-$31.30M-$21.60M-$11.74M-$8.87M
    Dividends paid$94.00K$0$0N/AN/AN/AN/AN/AN/AN/A
    Share repurchases$2.20M$0$0N/A$401.00K$0$0$3.46MN/AN/A
    Investing cash flow-$801.00K-$2.41M-$1.32M$6.73M-$9.84M-$730.00K-$813.00K-$1.01M-$594.00K-$324.00K
    Financing cash flow$35.85M-$6.81M$22.70M$207.00K$83.01M$2.37M$2.42M$97.04M$23.84M$4.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$1.24M-$1.01M-$9.42M$908.00K-$785.00K-$3.50M-$16.99M-$8.60M-$5.42M-$4.97M-$12.02M$2.13M
    Capital expenditures$470.00K$417.00K$197.00K$216.00K$114.00K$252.00K$219.00K$89.00K$386.00K$616.00K$375.00K$879.00K
    Free cash flow$768.00K-$1.43M-$9.62M$692.00K-$899.00K-$3.76M-$17.21M-$8.69M-$5.80M-$5.58M-$12.39M$1.25M
    Last 12 quarters

    Frequently Asked Questions About STIM

    What is Neuronetics' annual revenue?

    Neuronetics reported revenue of $149.16M for the fiscal year ended Dec 31, 2025.

    How fast is Neuronetics' revenue growing?

    Revenue was up 99.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 31.8%.

    Is Neuronetics profitable?

    No. Neuronetics reported net income of -$39.13M for the fiscal year ended Dec 31, 2025, with a net margin of -26.2%.

    How much free cash flow does STIM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$20.37M minus capital expenditures of $801.00K produced free cash flow of -$21.18M.

    How much debt does Neuronetics have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $65.81M, short-term debt of $500.00K and cash and equivalents of $28.13M.